(Posted By: Josi Creek)
The headline of this story links to a medical publication of a
case involving a woman suffering from multiple sclerosis who
experienced an acute tetra-ventricular hydrocephalus soon after the
beginning of immunomodulating treatment with natalizumab (Tysabri).
